Atai Life Sciences Nv logo

Atai Life Sciences Nv Share Price Today

(NASDAQ: ATAI)

Atai Life Sciences Nv share price is $1.61 & ₹140.02 as on 6 Mar 2025, 2.30 'hrs' IST

$1.61

0.06

(3.54%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Atai Life Sciences Nv share price in Dollar and Rupees. Guide to invest in Atai Life Sciences Nv stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Atai Life Sciences Nv, along with analyst recommendations, forecasts, and comprehensive financials.

Atai Life Sciences Nv share price movements

  • Today's Low: $1.55
    Today's High: $1.62

    Day's Volatility :4.63%

  • 52 Weeks Low: $1.03
    52 Weeks High: $2.85

    52 Weeks Volatility :63.86%

Atai Life Sciences Nv (ATAI) Returns

PeriodAtai Life Sciences NvSector (Health Care)Index (Russel 2000)
3 Months
8.05%
3.7%
0.0%
6 Months
31.97%
-2.8%
0.0%
1 Year
-19.1%
2.5%
0.0%
3 Years
-67.61%
12.9%
-11.6%

Atai Life Sciences Nv (ATAI) Key Statistics

in dollars & INR

Previous Close
$1.555
Open
$1.6
Today's High
$1.62
Today's Low
$1.545
Market Capitalization
$301.7M
Today's Volume
$1.8M
52 Week High
$2.85
52 Week Low
$1.03
Revenue TTM
$331.0K
EBITDA
$-103.6M
Earnings Per Share (EPS)
$-0.83
Profit Margin
0.0%
Quarterly Earnings Growth YOY
-0.97%
Return On Equity TTM
-62.77%

How to invest in Atai Life Sciences Nv Stock (ATAI) from India?

It is very easy for Indian residents to invest directly in Atai Life Sciences Nv from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Atai Life Sciences Nv stock in both Indian Rupees (INR) and US Dollars (USD). Search for Atai Life Sciences Nv or ATAI on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Atai Life Sciences Nv or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Atai Life Sciences Nv shares which would translate to 0.540 fractional shares of Atai Life Sciences Nv as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Atai Life Sciences Nv, in just a few clicks!

Returns in Atai Life Sciences Nv (ATAI) for Indian investors in Rupees

The Atai Life Sciences Nv stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Atai Life Sciences Nv investment value today

Current value as on today

₹85,853

Returns

₹14,147

(-14.15%)

Returns from Atai Life Sciences Nv Stock

₹19,095 (-19.1%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Atai Life Sciences Nv (ATAI)

642.86%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Investment in Atai Life Sciences Nv Shares from India has grown by 642.86% over the past 30 days, indicating increased transactional activity.

73%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Atai Life Sciences Nv Stock from India on INDmoney has increased by 73% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Atai Life Sciences Nv

  • Morgan Stanley - Brokerage Accounts

    1.72%

  • UBS Group AG

    1.00%

  • Millennium Management LLC

    0.51%

  • Davidson Kempner Capital Management LP

    0.49%

  • Brown University

    0.37%

  • Woodline Partners LP

    0.29%

Analyst Recommendation on Atai Life Sciences Nv

Buy

    92%Buy

    7%Hold

    0%Sell

Based on 13 Wall street analysts offering stock ratings for Atai Life Sciences Nv(by analysts ranked 0 to 5 stars)

Based on 13 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
12
11
12
Hold
1
1
2
Sell
0
0
0

Analyst Forecast on Atai Life Sciences Nv Stock (ATAI)

What analysts predicted

Upside of 396.89%

Target:

$8.00

Current:

$1.61

Insights on Atai Life Sciences Nv Stock (Ticker Symbol: ATAI)

  • Price Movement

    In the last 1 month, ATAI stock has moved down by -24.1%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 273.0K → 40.0K (in $), with an average decrease of 85.4% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -57.31M → -26.28M (in $), with an average increase of 118.0% per quarter
  • ATAI vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 85.6%
  • ATAI vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 51.6% return, outperforming this stock by 120.2%
  • Price to Sales

    ForATAI every $1 of sales, investors are willing to pay $805.0, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Atai Life Sciences Nv Technicals Summary

Sell

Neutral

Buy

Atai Life Sciences Nv is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Atai Life Sciences Nv (ATAI) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Atai Life Sciences Nv logo
-28.44%
31.97%
-19.1%
-67.61%
-91.72%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Atai Life Sciences Nv logo
NA
NA
NA
-0.76
-0.63
-0.26
NA
0.87
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Atai Life Sciences Nv logo
Buy
$301.7M
-91.72%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Atai Life Sciences Nv

Atai Life Sciences N.V., a clinical-stage biopharmaceutical company, develops and invests in various therapeutics to treat depression, anxiety, addiction, and other mental health disorders. Its product candidates include COMP360, a proprietary psilocybin which is in Phase 3 program; BPL-003, an intranasal formulation that is in Phase 2a and 2b clinical studies; TRD; VLS-01, an transmucosal film in Phase 1b clinical studies; and ELE-101, a serotonergic psychedelic that is in Phase 1/2a study, for the treatment of treatment resistant depression. The company also develop IBX-210, an intravenous formulation of ibogaine, and DMX-1002, an oral formulation of ibogaine indicated for the treatment of opioid use disorder; EMP-01, an oral formulation of an R-MDMA derivative being developed for the treatment of post-traumatic stress disorder; and EGX-A and EGX-B, psychedelic-like with novel, non-tryptamine structures with differentiated 5-HT receptor pharmacology. In addition, it offers RL-007, an orally bioavailable compound, which is a pro-cognitive neuromodulator for cognitive impairment associated with schizophrenia; and GRX-917, a deuterated etifoxine for the treatment of generalize anxiety disorder. Further, the company develops PCN-101, a subcutaneous formulation of R-ketamine, as a therapy for psychiatric indications initially focused on TRD; KUR-101, a formulation of deuterated mitragynine for the treatment of OUD; and RLS-01, indicated for treatment resistant depression. ATAI Life Sciences N.V. was founded in 2018 and is headquartered in Berlin, Germany with offices in New York and London.
Organization
Atai Life Sciences Nv
Employees
83
CEO
Dr. Srinivas G. Rao M.D., Ph.D.
Industry
Commercial Services

Management People of Atai Life Sciences Nv

NameTitle
Mr. Christian Angermayer
Founder & Chairman of the Supervisory Board
Dr. Srinivas G. Rao M.D., Ph.D.
Co-Founder & CEO
Ms. Anne Johnson
Chief Financial Officer
Dr. Gerd G. Kochendoerfer Ph.D.
Chief Operating Officer
Mr. Frank Stegert
Vice President of Investment & Venture Management
Dr. Glenn Short Ph.D.
Chief Scientific Officer
Mr. Ryan Barrett J.D.
General Counsel & Corporate Secretary
Dr. Sahil V. Kirpekar M.D.
Chief Business Officer
Dr. Kevin Craig M.D.
Chief Medical Officer

Important FAQs about investing in ATAI Stock from India :

What is Atai Life Sciences Nv share price today?

Atai Life Sciences Nv share price today stands at $1.61, Open: $1.60 ; Previous Close: $1.56 ; High: $1.62 ; Low: $1.55 ; 52 Week High: $2.85 ; 52 Week Low: $1.03.

The stock opens at $1.60, after a previous close of $1.56. The stock reached a daily high of $1.62 and a low of $1.55, with a 52-week high of $2.85 and a 52-week low of $1.03.

Can Indians buy Atai Life Sciences Nv shares?

Yes, Indians can invest in the Atai Life Sciences Nv (ATAI) from India.

With INDmoney, you can buy Atai Life Sciences Nv at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Atai Life Sciences Nv at zero transaction cost.

How can I buy Atai Life Sciences Nv shares from India?

It is very easy to buy Atai Life Sciences Nv from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Atai Life Sciences Nv (ATAI) be purchased?

Yes, you can buy fractional shares of Atai Life Sciences Nv with INDmoney app.

What are the documents required to start investing in Atai Life Sciences Nv stocks?

To start investing in Atai Life Sciences Nv, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Atai Life Sciences Nv Stock (ATAI)?

Today’s highest price of Atai Life Sciences Nv (ATAI) is $1.62.

Today’s lowest price of Atai Life Sciences Nv (ATAI) is $1.55.

What is today's market capitalisation of Atai Life Sciences Nv?

Today's market capitalisation of Atai Life Sciences Nv ATAI is 301.7M

What is the 52 Week High and Low Range of Atai Life Sciences Nv Stock (ATAI)?

  • 52 Week High

    $2.85

  • 52 Week Low

    $1.03

What are the historical returns of Atai Life Sciences Nv (ATAI)?

  • 1 Month Returns

    -28.44%

  • 3 Months Returns

    31.97%

  • 1 Year Returns

    -19.1%

  • 5 Years Returns

    -91.72%

Who is the Chief Executive Officer (CEO) of Atai Life Sciences Nv ?

Dr. Srinivas G. Rao M.D., Ph.D. is the current Chief Executive Officer (CEO) of Atai Life Sciences Nv.